0:36So today I'm going to talk about some work that our R&D team have been doing looking at optimising non-viral engineering of resting or naive non proliferative T cells and why I wanted to talk proliferative in a talk is beyond me. 0:56So I'm really going to talk just a little bit about why we wanted to look at the naive non proliferative population, talk a little bit about our process that...